Delpharm Bladel

Delpharm Bladel is a contract development and manufacturing organization (CDMO) based in Bladel, Netherlands, specializing in the manufacture and packaging of pasty and non-sterile liquid pharmaceutical forms. Acquired by the Delpharm Group from Famar in 2019, the facility provides industrial flexibility for a wide range of dosage forms, including creams, ointments, solutions, syrups, oral suspensions, and topical or nasal sprays. The site operates under strict European Medicines Agency (EMA) and other international regulatory standards, enabling the export of medicines globally. With capabilities to handle batch sizes up to 6,000 liters and fill small-volume bottles starting from 3 ml, Delpharm Bladel serves as a key manufacturing partner for global pharmaceutical companies.